Pendal Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | $1.85M | Sell |
19,898
-94,511
| -83% | -$8.81M | 0.02% | 220 |
|
2022
Q3 | $10.9M | Buy |
114,409
+80,650
| +239% | +$7.69M | 0.11% | 106 |
|
2022
Q2 | $3.13M | Buy |
33,759
+24,740
| +274% | +$2.29M | 0.03% | 168 |
|
2022
Q1 | $913K | Sell |
9,019
-15,549
| -63% | -$1.57M | 0.01% | 345 |
|
2021
Q4 | $2.53M | Buy |
24,568
+10,423
| +74% | +$1.08M | 0.02% | 215 |
|
2021
Q3 | $1.2M | Sell |
14,145
-25,858
| -65% | -$2.19M | 0.01% | 300 |
|
2021
Q2 | $3.34M | Buy |
40,003
+32,750
| +452% | +$2.73M | 0.03% | 185 |
|
2021
Q1 | $546K | Sell |
7,253
-15,575
| -68% | -$1.17M | 0.01% | 396 |
|
2020
Q4 | $1.56M | Sell |
22,828
-19,062
| -46% | -$1.3M | 0.02% | 242 |
|
2020
Q3 | $2.45M | Buy |
41,890
+258
| +0.6% | +$15.1K | 0.03% | 151 |
|
2020
Q2 | $2.71M | Buy |
+41,632
| New | +$2.71M | 0.04% | 143 |
|
2019
Q2 | – | Sell |
-1,097
| Closed | -$59.2K | – | 438 |
|
2019
Q1 | $59.2K | Buy |
+1,097
| New | +$59.2K | ﹤0.01% | 424 |
|
2018
Q1 | – | Sell |
-129,423
| Closed | -$9.38M | – | 469 |
|
2017
Q4 | $9.38M | Buy |
129,423
+123,186
| +1,975% | +$8.93M | 0.12% | 121 |
|
2017
Q3 | $507K | Buy |
6,237
+5,611
| +896% | +$456K | 0.01% | 372 |
|
2017
Q2 | $50.4K | Buy |
+626
| New | +$50.4K | ﹤0.01% | 448 |
|